ConMed Corporation (CNMD):企業の財務・戦略的SWOT分析

◆英語タイトル:ConMed Corporation (CNMD) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2857
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ConMed Corporation (CNMD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ConMed Corporation (ConMed) is a medical technology company which manufactures and sells surgical devices and instruments for minimally invasive procedures and monitoring. The company’s major products include arthroscopes, reconstructive systems, bronchoscopy devices endoscopic ligator kit, stone removal balloon, trocars, graspers, scissors, suction irrigation devices, thermal tissue fusion system, electrosurgical generators, smoke evacuation pencil, pencil sheath, saws, blades, endomechanical instrumentation, and surgical visualization equipment. ConMed caters its products to orthopedic, general surgery, gynecology, gastroenterology, pulmonology, anesthesiology and sports medicine markets. The company sells its products through direct sales force and medical specialty distributors. It operates in the Americas, Europe, Middle East and Asia-Pacific. ConMed is headquartered in New York, the US.

ConMed Corporation Key Recent Developments

Aug 01,2018: CONMED announces second quarter 2018 financial results
Apr 25,2018: CONMED Announces First Quarter 2018 Financial Results
Jan 31,2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results
Jan 02,2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer
Nov 02,2017: CONMED Announces Retirement of Chief Financial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
ConMed Corporation – Key Facts 6
ConMed Corporation – Key Employees 7
ConMed Corporation – Key Employee Biographies 8
ConMed Corporation – Major Products and Services 9
ConMed Corporation – History 12
ConMed Corporation – Company Statement 15
ConMed Corporation – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 19
Company Overview 19
ConMed Corporation – Business Description 20
Product Category: General Surgery 20
Overview 20
Performance 20
Product Category: Orthopedic Surgery 20
Overview 20
Performance 21
Geographical Segment: Americas (excluding the US) 21
Performance 21
Geographical Segment: Asia Pacific 21
Performance 21
Geographical Segment: Europe, Middle East & Africa 21
Performance 21
Geographical Segment: United States 21
Performance 21
R&D Overview 21
ConMed Corporation – Corporate Strategy 22
ConMed Corporation – SWOT Analysis 23
SWOT Analysis – Overview 23
ConMed Corporation – Strengths 23
ConMed Corporation – Weaknesses 24
ConMed Corporation – Opportunities 25
ConMed Corporation – Threats 26
ConMed Corporation – Key Competitors 27
Section 3 – Company Financial Ratios 28
Financial Ratios – Capital Market Ratios 28
Financial Ratios – Annual Ratios 29
Performance Chart 32
Financial Performance 32
Financial Ratios – Interim Ratios 33
Financial Ratios – Ratio Charts 34
Section 4 – Company’s Lifesciences Financial Deals and Alliances 35
ConMed Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 35
ConMed Corporation, Medical Equipment, Deals By Type, 2012 to YTD 2018 36
ConMed Corporation, Recent Deals Summary 37
Section 5 – Company’s Recent Developments 38
Aug 01, 2018: CONMED announces second quarter 2018 financial results 38
Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results 39
Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results 40
Jan 02, 2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer 42
Nov 02, 2017: CONMED Announces Retirement of Chief Financial Officer 43
Nov 02, 2017: CONMED Announces Third Quarter 2017 Financial Results 44
Jul 26, 2017: CONMED Announces Second Quarter 2017 Financial Results 45
Apr 26, 2017: CONMED Announces First Quarter 2017 Financial Results 46
Apr 13, 2017: Jury Awards $10 Million In Punitive Damages Against SurgiQuest, A Subsidiary Of CONMED Corporation For False Advertising In Dispute With Lexion Medical 47
Apr 11, 2017: CONMED Announces Jury Verdict in Delaware Litigation Against SurgiQuest 48
Section 6 – Appendix 49
Methodology 49
Ratio Definitions 49
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
ConMed Corporation, Key Facts 6
ConMed Corporation, Key Employees 7
ConMed Corporation, Key Employee Biographies 8
ConMed Corporation, Major Products and Services 9
ConMed Corporation, History 12
ConMed Corporation, Other Locations 16
ConMed Corporation, Subsidiaries 17
ConMed Corporation, Key Competitors 27
ConMed Corporation, Ratios based on current share price 28
ConMed Corporation, Annual Ratios 29
ConMed Corporation, Annual Ratios (Cont...1) 30
ConMed Corporation, Annual Ratios (Cont...2) 31
ConMed Corporation, Interim Ratios 33
ConMed Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 35
ConMed Corporation, Medical Equipment, Deals By Type, 2012 to YTD 2018 36
ConMed Corporation, Recent Deals Summary 37
Currency Codes 49
Capital Market Ratios 49
Equity Ratios 50
Profitability Ratios 50
Cost Ratios 51
Liquidity Ratios 51
Leverage Ratios 52
Efficiency Ratios 52

List of Figures
ConMed Corporation, Performance Chart (2013 - 2017) 32
ConMed Corporation, Ratio Charts 34
ConMed Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 35
ConMed Corporation, Medical Equipment, Deals by Type, 2012 to YTD 2018 36

★海外企業調査レポート[ConMed Corporation (CNMD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Global Orthopaedic Technology Pty Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Global Orthopaedic Technology Pty Ltd (Global) is a medical device company that designs and manufactures orthopaedic implants. The company offers orthopaedic implants for knee, hip and spine. Its hip products include global cup, bioball system, paragon stem, absolut cemented stem, and unisyn …
  • Opthea Ltd (OPT)-医療機器分野:企業M&A・提携分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd is a provider of research and development of angiogenesis and vascular leakage-based treatments for cancer focusing on vascular endothelial growth factors. The company’s pipeline products comprise VEGF-C, VEGF-D and VEGFR-3. Opthea’s d …
  • Nexira:戦略・SWOT・企業財務分析
    Nexira - Strategy, SWOT and Corporate Finance Report Summary Nexira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • UNITIKA LTD.:企業の戦略・SWOT・財務情報
    UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report Summary UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • VEON Ltd:企業の戦略・SWOT・財務情報
    VEON Ltd - Strategy, SWOT and Corporate Finance Report Summary VEON Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Altra Industrial Motion Corp (AIMC):企業の財務・戦略的SWOT分析
    Summary Altra Industrial Motion Corp (Altra Industries), formerly Altra Holdings Inc is an industrial equipment company that designs and manufactures power transmission and motion control products. The company offers products such as electric clutches and brakes, couplings, heavy duty clutches and b …
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Catholic Health Initiatives:企業のM&A・事業提携・投資動向
    Catholic Health Initiatives - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Catholic Health Initiatives Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Commonwealth Scientific and Industrial Research Organisation-医療機器分野:企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • CBS Corporation:戦略・SWOT・企業財務分析
    CBS Corporation - Strategy, SWOT and Corporate Finance Report Summary CBS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Fresh Del Monte Produce Inc (FDP):企業の財務・戦略的SWOT分析
    Fresh Del Monte Produce Inc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Inframark LLC:企業の戦略的SWOT分析
    Inframark LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Ascent Solar Technologies Inc (ASTI):電力:M&Aディール及び事業提携情報
    Summary Ascent Solar Technologies, Inc. (Ascent solar) designs, develops and manufactures thin-film photovoltaic modules. It pioneered the thin-film copper-indium-gallium-diselenide (CIGS) photovoltaic technology. The company employs monolithic integration process, which helps improve efficiency and …
  • Turbo Power Systems Ltd:企業の戦略的SWOT分析
    Turbo Power Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Kenya Power and Lighting Co Ltd:発電所・企業SWOT分析
    Kenya Power and Lighting Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • B.L. Kashyap and Sons Ltd:企業の戦略・SWOT・財務情報
    B.L. Kashyap and Sons Ltd - Strategy, SWOT and Corporate Finance Report Summary B.L. Kashyap and Sons Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PCM Inc:戦略・SWOT・企業財務分析
    PCM Inc - Strategy, SWOT and Corporate Finance Report Summary PCM Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Nohla Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nohla Therapeutics Inc (Nohla Therapeutics) focuses on the development of universal, off-the-shelf cell therapies for the treatment of hematologic malignancies and other critical diseases. The company develops clinical, preclinical and discovery programs based on its proprietary notch ligand …
  • Enanta Pharmaceuticals Inc (ENTA):企業の財務・戦略的SWOT分析
    Summary Enanta Pharmaceuticals Inc (Enanta) is a biotechnology company that discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company’s lead product candidate includes EDP-305, a farnesoid X receptor (FXR) agonist intended for the treatment of …
  • Coolgardie Minerals Ltd (CM1):企業の財務・戦略的SWOT分析
    Coolgardie Minerals Ltd (CM1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆